Real-World Evidence — Where Are We Now?

Similar Works

Action	Title	Year	Authors
+ PDF Chat	Examining the Use of Real‐World Evidence in the Regulatory Process	2019	Brett K. Beaulieu‐Jones Samuel G. Finlayson William Yuan Russ B. Altman Isaac S. Kohane Vinay Prasad Kun‐Hsing Yu
+	The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License Applications	2021	Christina A. Purpura Elizabeth M. Garry Nicholaas Honig Abigail E. Case Jeremy A. Rassen
+ PDF Chat	When can real‐world data generate real‐world evidence?	2023	Motiur Rahman Gerald J. Dal Pan Peter Stein Mark Levenson Stefanie Kraus Aloka Chakravarty Donna R. Rivera Richard A. Forshee John Concato
+	For insights into the real world, consider real-world data	2022	Sana Raoof Razelle Kurzrock
+	Real‐World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases	2024	Stefanie Prilla Sophie Groeneveld Alexandra Păcurariu María Clara Restrepo–Méndez Patrice Verpillat Carla Torre Christian Gärtner Peter G. M. Mol Frauke Naumann‐Winter Kieran C. Breen
+	Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product Effectiveness	2021	Nirosha Mahendraratnam Kerra Mercon Mira Gill Laura Benzing Mark McClellan
+ PDF Chat	Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective	2024	Jie Chen Susan Gruber Hana Lee Haitao Chu Shiowjen Lee Haijun Tian Yan Wang Weili He Thomas Jemielita Yang Song
+	Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective	2025	Jie Chen Susan Gruber Hana Lee Haitao Chu Shiowjen Lee Haijun Tian Yan Wang Weili He Thomas Jemielita Yang Song
+ PDF Chat	4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies	2020	Jessica Pham Eunjoo Pacifici
+ PDF Chat	Real-World Evidence: A Primer	2023	Amit Dang
+ PDF Chat	Advancing the utilization of real‐world data and real‐world evidence in clinical pharmacology and translational research—Proceedings from the <scp>ASCPT</scp> 2023 preconference workshop	2024	Jing Liu Karen Rowland Yeo Almut G. Winterstein Simon Dagenais Qi Liu Jeffrey S. Barrett Rui Zhu Cyrus Ghobadi Amita Datta‐Mannan Joy C. Hsu
+	The use of real-world evidence to support FDA post-approval study requirements for oncology drugs	2022	Marjorie E. Zettler
+ PDF Chat	Real-world evidence and product development: Opportunities, challenges and risk mitigation	2021	Poobalan Naidoo Célia Bouharati Virendra Rambiritch Nadina Jose Sumanth Karamchand Robert Ćhilton Rory Leisegang
+ PDF Chat	Real World Data and Evidence: Support for Drug Approval	2019	Aliza M. Thompson Mary Southworth
+ PDF Chat	Real-World Data for the Drug Development in the Digital Era	2022	Xianchen Liu
+ PDF Chat	What Does It Take to Transform Real‐World Data Into Real‐World Evidence?	2019	Anuradha Ramamoorthy Shiew‐Mei Huang
+ PDF Chat	Real-world clinical practice in health technology assessment: state of the art for 2022	2023	А. А. Курылев A. A. Zhuravkov А. С. Колбин
+	Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review	2022	Kapil Khambholja Manish Gehani
+ PDF Chat	Should real-world evidence be incorporated into regulatory approvals?	2018	Ernest Spitzer Christopher P. Cannon Patrick W. Serruys
+	Clinical Evidence 2030	2025	Peter Arlett Denise Umuhire Patrice Verpillat Paolo Foggi Ulla Liminga Bruno Sepodes Marianne Lunzer Brian Aylward Spiros Vamvakas Kit C. B. Roes

Works That Cite This (31)

Action	Title	Year	Authors
+	Alternative evidence in drug development and regulatory science	2023	Nora A. Janjan Patrick J. Silva Kenneth S. Ramos Marcia G. Ory Matthew Lee Smith
+ PDF Chat	When can real‐world data generate real‐world evidence?	2023	Motiur Rahman Gerald J. Dal Pan Peter Stein Mark Levenson Stefanie Kraus Aloka Chakravarty Donna R. Rivera Richard A. Forshee John Concato
+ PDF Chat	Quantitative bias analysis methods for summary level epidemiologic data in the peer-reviewed literature: a systematic review	2024	Xiaoting Shi Ziang Liu Mingfeng Zhang Hua Wei Jie Li Joo-Yeon Lee Sai Dharmarajan Kate Nyhan Ashley I. Naimi Timothy L. Lash
+	Quantitative bias analysis methods for summary-level epidemiologic data in the peer-reviewed literature: a systematic review	2024	Xiaoting Shi Ziang Liu Mingfeng Zhang Hua Wei Jie Li Joo-Yeon Lee Sai Dharmarajan Kate Nyhan Ashley I. Naimi Timothy L. Lash
+ PDF Chat	Verknüpfung von randomisierten kontrollierten Studien und Real World Data	2023	Tim Friede Christian Röver Tim Mathes
+ PDF Chat	Feasibility of Identifying Factors Related to Alzheimer’s Disease and Related Dementia in Real-World Data	2024	Aokun Chen Qian Li Yü Huang Yongqiu Li Yu-Neng Chuang Xia Hu Serena Guo Yonghui Wu Yi Guo Jiang Bian
+	FOUNTAIN: a modular research platform for integrated real-world evidence generation	2024	Nikolaus G. Oberprieler Manel Pladevall Catherine B. Johannes J. Bradley Layton Asieh Golozar Martin Lavallee Fangfang Liu Maria Kubin David Vizcaya
+ PDF Chat	Comparison of two assessments of real‐world data and real‐world evidence for regulatory decision‐making	2023	Lily Yuan Motiur Rahman John Concato
+ PDF Chat	Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice	2023	Nancy A Dreyer Christina Mack
+	Evidence on Real-World Data and Real-World Evidence as a Driver for Precision Medicine Implementation in Pharmacy Practice	2023	Rachele Hendricks‐Sturrup Dixil Francis

Works Cited by This (0)

Action	Title	Year	Authors